Daily clinical lab news - Labmedica.com

We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

hp

Advertise with Us

Latest Issue

Expo Clinical Chem.Molecular DiagnosticsHematologyImmunologyMicrobiologyPathologyTechnologyIndustry Events Webinars

Expo Clinical Chem.Molecular DiagnosticsHematologyImmunologyMicrobiologyPathologyTechnologyIndustry Events Webinars Advertise with Us

GLOBE SCIENTIFIC, LLC

EUROIMMUN AG

Merck Life Science KGaA

GC Medical Science corp.

Featured Whitepaper

Boule Diagnostics AG:
Slide preparation for WBC differential by manual microscopy

Download Mobile App

Featured Video

ADLM:
ADLM 2025 – Bring the wonder to the premier global laboratory medicine conference

Trending Articles

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Real-Time Genome Sequencing Detects Dangerous Superbug Causing Hospital Infections

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

Treatment Switching Guided by Liquid Biopsy Blood Tests Improves Outcomes for Breast Cancer Patients

Simple Paper Test Offers Early Cancer Diagnosis

QuidelOrtho to Acquire MDx Company LEX Diagnostics

AI Tool Identifies Gene Combinations Causing Complex Illnesses

Events

more events

19 Jun 2025 - 23 Jun 2025

ASM Microbe 2025 – American Society for Microbiology

21 Jun 2025 - 25 Jun 2025

ISTH 2025 Congress – International Society on Thrombosis and Haemostasis

24 Jun 2025 - 27 Jun 2025

FOCIS 2025 – Annual Meeting of the Federation of Clinical Immunology Societies

DIASYS DIAGNOSTIC SYSTEMS

Partner Sites

HospiMedica

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

Dissolvable Microarray Technology Delivers Drug and Vaccine Via Patch

AI Guidance Tool Prevents Spread of C. Difficile Infection in Hospital Settings

Patient-Specific Implant Techniques Could Reduce Stroke Risk in Patients with LVADs

New Method for Labeling T Cells in Immunotherapy to Make Treatments Safer

First-Of-Its-Kind Quantitative Method Assesses Opioid Exposure in Newborns

Image: New automated lab procedures can detect opioids in tiny amounts of blood (Photo courtesy of Tripathi Lab/Brown University)

Researchers have developed new automated lab procedures for detecting opioids in tiny amounts of blood.
Read more
17 Jun 2025

Paper-Based Devices Outperform Existing Methods in Diagnosing Asymptomatic Malaria

17 Jun 2025

Pioneering Saliva-Based Multiomic Platform to Transform Early Oral Cancer Detection

17 Jun 2025

New POC Biosensing Technology Improves Detection of Molecular Biomarkers

17 Jun 2025

Fully Automated Detection System Revolutionizes Point-Of-Care Testing

16 Jun 2025

World’s First Urine-Based HPV Test to Transform Cervical Cancer Screening

16 Jun 2025

Visit expo >

Gold Member

Antipsychotic TDM Assays

Saladax Antipsychotic Assays

3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler

New

Mini Vortex Mixer

Vornado

New

Francisella Tularensis Test

TULAREMIA VIRCLIA IgG+IgM MONOTEST

In Other News

Image: bioMérieux’s acquisition of Day Zero Diagnostics’ assets aims to strengthen its NGS capabilities (Photo courtesy of bioMérieux)

bioMérieux Acquires Day Zero Diagnostics Solutions and Technologies

bioMérieux (Marcy l’Étoile, France), a world leader in the field of in vitro diagnostics, has agreed to acquire the assets of Day Zero Diagnostics (Watertown, MA, USA), an infectious disease diagnostics company using genome sequencing and machine learning to combat the rise of antibiotic-resistant infections. Read more
17 Jun 2025 | Industry

Image: The new AI method makes cancer tracking faster and easier using blood tests (Photo courtesy of A*STAR GIS)

AI Method Speeds Up Cancer Tracking Using Blood Tests

Current techniques for detecting cancer DNA in the bloodstream, referred to as circulating tumor DNA (ctDNA), often depend on complex and costly DNA sequencing to identify common mutations associated with cancer. Read more
16 Jun 2025 | Pathology

Image: Device architecture and measurement setup of an HJD-NP, with n-type MoS2 and p-type WSe2 (Photo courtesy of Grainger College of Engineering)

Novel Nanopore Sensing Platform Paves Way for Solid-State, Label-Free DNA Sequencing Technologies

Nanopore sensors are extremely small devices designed to detect and examine individual molecules by monitoring ionic changes as these molecules move through nanoscale pores. Read more
16 Jun 2025 | Molecular Diagnostics

Image: The AI tool helps to automate the counting of different blood cell types contained in a blood or bone marrow sample (Photo courtesy of MSK)

New AI Tool Improves Blood Cancer Diagnosis

Traditionally, diagnosing blood and bone marrow cancers has involved doctors manually examining and classifying hundreds of cells under a microscope—an approach that is time-consuming but essential for identifying disease and determining cancer stage. Read more
16 Jun 2025 | Pathology

Image: Gut microbes may help in recognizing and treating pancreatic cancer (Photo courtesy of Adobe Stock)

Gut Microbes Could Enable Early Detection and Treatment of Pancreatic Cancer

Pancreatic cancer remains one of the most serious and challenging diseases in oncology due to its difficulty in detection and limited treatment options. Read more
13 Jun 2025 | Molecular Diagnostics

Image: Isolation of fibrotic regions from aged liver tissue, followed by single-cell transcriptome analysis and validation in a fibrosis model (Photo courtesy of KAIST)

Novel Platform Technology Predicts Diseases by Early Detection of Aging Signals in Liver Tissue

Aging and chronic diseases are marked by the slow buildup of subtle tissue alterations over extended periods. Read more
13 Jun 2025 | Pathology

Image: The U.S. FDA-cleared IntelliSep rapid host response diagnostic represents a breakthrough in sepsis care (Photo courtesy of Cytovale)

Rapid Diagnostic Test Slashes Sepsis Mortality by 39%

Sepsis remains one of the most challenging and fatal conditions in contemporary healthcare, accounting for nearly one-third of all hospital-related deaths in the United States. Read more
13 Jun 2025 | Microbiology

Image: The knowledge transfer partnership will further develop technology to rapidly diagnose serious and high-risk infectious diseases (Photo courtesy of Aston University)

Aston University and BG Research Partner to Commercialize Groundbreaking Medical Diagnostic

Technology that can rapidly diagnose high-consequence infectious diseases will take a major step forward towards commercialization, thanks to a new partnership. Read more
13 Jun 2025 | Industry

Image: A survey of 150+ scientists has revealed data challenges in lab digitization (Photo courtesy of Titian Software)

Enhanced Lab Data Management and AI Critical to Labs of the Future, Finds Survey

Data plays a key role in the transformation of today’s digital laboratories, acting both as a key challenge and a catalyst for innovation, as revealed by a survey of over 150 scientists. Read more
13 Jun 2025 | Technology

Image: The proprietary multiomic platform unlocks disease-associated biomarkers from a range of biological sources (Photo courtesy of Tagomics)

Highly Sensitive and Specific Test to Enable Early Detection of Colorectal Cancer

A highly sensitive and specific diagnostic test for the early detection and treatment of colorectal cancer could enable treatment at the earliest possible stages of disease development. Read more
12 Jun 2025 | Molecular Diagnostics

Image: The Genedrive CYP2C19 ID rapid POC test is used in conjunction with the Genedrive system (Photo courtesy of genedrive plc)

Point-of-Care PGx Test Enables Rapid Appropriate Antiplatelet Prescription for Stroke Patients

Clopidogrel is an antiplatelet treatment for secondary prevention of minor strokes and transient ischemic attack (TIA), also known as a mini-stroke. Read more
12 Jun 2025 | Molecular Diagnostics

$Image: A new DNA sequencing technology aims to improve treatment for infections following bone fractures (Photo courtesy of MicroGenDX)$

Rapid DNA Sequencing Technology Could Improve Treatment for Fracture-Related Infections

Fracture-related infections are a serious complication after broken bone surgeries, potentially arising at any point during treatment. Read more
12 Jun 2025 | Molecular Diagnostics

Image: A new biomarker panel can significantly improve the prediction of CKD progression (Photo courtesy of Adobe Stock)

New Biomarker Panel Improves Assessment of Pediatric Chronic Kidney Disease

Pediatric chronic kidney disease (CKD) is a serious condition that can advance to kidney failure, requiring dialysis or transplantation. Read more
12 Jun 2025 | Molecular Diagnostics

Image: The Healthspan Proteomic Score is a strong predictor of disease and mortality risk (Photo courtesy of Bernard L. Cook III/UConn School of Medicine)

Blood-Based Proteomic Score Predicts Healthspan and Disease Risk

While aging is inevitable, how each person ages—and how long they remain healthy—varies greatly. Accurately predicting who will live longer in good health, known as healthspan, remains a challenge. Read more
12 Jun 2025 | Molecular Diagnostics

Channels

Clinical Chemistry

view channel

Image: New research has linked skin barrier dysfunction to pediatric eosinophilic esophagitis (Photo courtesy of 123RF)

Simple Skin Test Could Revolutionize Diagnosis of Pediatric Eosinophilic Esophagitis

Eosinophilic esophagitis (EoE) is a chronic, food allergen-driven condition marked by inflammation and damage to the esophageal lining. Diagnosing EoE in children remains a clinical challenge, especially... Read more

Image: A new diagnostic tool shines a powerful new light into the viral darkness (Photo courtesy of Adobe Stock)

Portable Diagnostic Tool Uses Bioluminescence to Detect Viruses at POC

Point-of-care diagnostics have become crucial tools in many households, enabling individuals to measure blood sugar, conduct pregnancy tests, and even perform their own COVID-19 assays. These diagnostics... Read more

Image: The POC device rapidly predicts neonatal respiratory disease at birth in the NICU (Photo courtesy of SIME Diagnostics)

AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress

Each year, approximately 300,000 babies in the United States are born between 32 and 36 weeks' gestation, according to national health data. This group is at an elevated risk for respiratory distress,... Read more

Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel

Image: The new method uses a generative AI model to amplify limited gene expression data (Photo courtesy of Camila Felix/Northwestern University)

AI Tool Identifies Gene Combinations Causing Complex Illnesses

For years, scientists have faced significant challenges in decoding the genetic basis of complex diseases like diabetes, asthma and cancer. Traditional methods such as genome-wide association studies often... Read more

Image: The MammaPrint assay can help guide chemotherapy decisions in older women (Photo courtesy of Adobe Stock)

Genomic Test Guides Chemotherapy Decisions in Older Breast Cancer Population

Findings from a study presented at the 2025 American Society of Clinical Oncology Annual Meeting suggest that a novel genomic assay could support treatment decision-making by identifying older patients... Read more

Image: A microfluidic device barely larger than a U.S. quarter can detect rare genetic mutations from a single drop of blood (Photo courtesy of Mahtab Kokabi/Javanmard Lab)

Portable Device Detects Rare Genetic Mutations from Single Drop of Blood

Current genetic testing methods often take days or even weeks to detect rare mutations, delaying timely diagnosis and treatment, especially for conditions like hereditary transthyretin amyloidosis, which... Read more

ctDNA Blood Tests Improve Lung Cancer Diagnosis

Lung cancer remains a major global health burden, being both the most frequently diagnosed cancer and the leading cause of cancer-related mortality worldwide. When it spreads to other parts of the body,... Read more

Hematology

view channel

Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Image: The FINDER multifunctional testing platform can run multiple types of tests and deliver rapid results for near-patient use (Photo courtesy of Baebies)

First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes

Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read more

Image: The 3-parameter CCRS model was devised specifically for patients diagnosed with clonal cytopenia (Photo courtesy of 123RF)

New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder

Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more

Image: The technology has the unique ability to detect challenging RhD variants that are typically excluded by other commercial tests (Photo courtesy of BillionToOne)

Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy

In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more

Immunology

view channel

Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Image: Switching to an experimental drug after liquid biopsy detection of breast cancer recurrence can improve outcomes (Photo courtesy of Shutterstock)

Treatment Switching Guided by Liquid Biopsy Blood Tests Improves Outcomes for Breast Cancer Patients

Standard treatment for patients with advanced estrogen receptor (ER)-positive, HER2-negative breast cancer, a subtype driven by estrogen receptors that fuel tumor growth, often involves aromatase inhibitors,... Read more

Image: Custom hardware and software for the real-time detection of immune cell biophysical signatures in NICU (Photo courtesy of Pediatric Research, DOI:10.1038/s41390-025-03952-y)

First-Of-Its-Kind Device Profiles Newborns' Immune Function Using Single Blood Drop

Premature infants are highly susceptible to severe and life-threatening conditions, such as sepsis and necrotizing enterocolitis (NEC). Newborn sepsis, which is a bloodstream infection occurring in the... Read more

Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel

Image: The LIAISON PLEX® Gram-Positive Blood Culture Assay runs on the on the LIAISON PLEX instrument (Photo courtesy of Diasorin)

Blood Culture Assay Enhances Diagnostic Stewardship Through Targeted Panel Selection

Each year, around 250,000 individuals in the US are diagnosed with bloodstream infections (BSIs). Sepsis caused by these infections carries a mortality rate ranging from 16% to 40%, and any delay in administering... Read more

Image: Cutting-edge hospital genomics initiative takes on dangerous superbug (Photo courtesy of 123RF)

Real-Time Genome Sequencing Detects Dangerous Superbug Causing Hospital Infections

Superbug infections caused by Staphylococcus aureus, or ‘golden staph’, are notoriously difficult to treat and claim over one million lives globally each year. These bacteria can rapidly develop resistance... Read more

Diagnostic Test Accurately Detects Colorectal Cancer by Identifying Microbial Signature in Gut Bacteria

Colorectal cancer remains one of the deadliest and most common forms of cancer worldwide, with only 40% of cases diagnosed before metastasis. Current screening methods, like colonoscopy, are invasive and... Read more

Image: PowerBlade is a portable device that uses a drop of blood and an automated sequence of steps to efficiently detect sepsis (Photo courtesy of NRC)

Rapid Bedside Test Predicts Sepsis with Over 90% Accuracy

Sepsis is a severe response to an infection that causes the immune system to attack the body's own organs and tissues, potentially leading to organ failure and death if not addressed promptly.... Read more

Pathology

view channel

Image: The AI model compares the epigenetic data of unknown tumors to the fingerprints of over 8,000 reference tumors (Photo courtesy of Philipp Euskirchen/Charité)

AI Model Detects More Than 170 Cancer Types

Diagnosing brain tumors can be especially difficult when the tumor is located in a region where biopsies pose high risks. In such scenarios, where obtaining tissue samples is not feasible, conventional... Read more

Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Image: A new at-home self-collection device aims to reduce the screening gap for cervical cancer (Photo courtesy of CU School of Medicine)

New At-Home Cervical Cancer Screening Device to Increase Accessibility for Patients

Cervical cancer is typically linked to certain types of human papillomavirus (HPV), which is passed through sexual contact. While many people are infected with HPV, only a small percentage will develop... Read more

Technology

view channel

Image: Structure of the herpes virus, nanopore module, and its waveform (Hashida et al., PNAS Nexus (2025), doi.org/10.1093/pnasnexus/pgaf161)

AI-Assisted Non-DNA Based Test Identifies Viral Infections in Minutes

Confirming viral infections typically involves DNA sequencing tests, which take hours and may not be available on-site. Moreover, these tests cannot differentiate between live and inactive virus particles.... Read more

Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more

Image: The second-generation sampler currently under development (Photo courtesy of Breathe BioMedical)

Breath Test to Enable Early Detection of Breast Cancer

Mammograms often fail to detect breast cancer in women with dense breast tissue, missing up to 60% of cases due to reduced image clarity. Breath analytics has the potential to allow for timely detection... Read more

Image: Concept of biosensor integrated into hygiene pads enabling direct semi-quantitative analysis of biomarkers in unprocessed menstruation blood (Photo courtesy of Dosnon, L et al. DOI: 10.1002/advs.202505170)

First Ever Technology Recognizes Disease Biomarkers Directly in Menstrual Blood in Sanitary Towels

Over 1.8 billion people menstruate worldwide, yet menstrual blood has been largely overlooked in medical practice. This blood contains hundreds of proteins, many of which correlate with their concentration... Read more

Industry

view channel

Image: The collaboration aims to speed up the adoption of ultrasensitive immunoassays incorporating single-molecule counting technology (Photo courtesy of Fujirebio)

Fujirebio Collaborates with Stanford Medicine to Advance Infectious Disease Research

Fujirebio (Tokyo, Japan) has entered into a collaboration with Stanford Medicine (Palo Alto, CA, USA) to accelerate the adoption of ultrasensitive immunoassays that incorporate single-molecule counting... Read more

Image: The LEX system brings together high speed and high sensitivity in a PCR molecular system to redefine POC diagnostics (Photo courtesy of LEX Diagnostics)

QuidelOrtho to Acquire MDx Company LEX Diagnostics

QuidelOrtho Corporation (San Diego, CA, USA) has announced a refocusing of its molecular diagnostics strategy which now includes acquiring LEX Diagnostics (Cambridgeshire, UK) and discontinuing development... Read more

Image: The new partnerships enhance QIAGEN’s capabilities to support pharma partner clinical trials using QIAcuity digital PCR (Photo courtesy of QIAGEN)

QIAGEN Enters into New Strategic Partnerships for Expanding MRD Testing Portfolio in Oncology

Minimal residual disease (MRD) testing offers a highly sensitive way to monitor treatment response, identify patients at risk of relapse before symptoms appear and inform decisions on therapy usage.... Read more

Danaher and AstraZeneca Partner on Next Generation AI-Powered Diagnostics

Danaher Corporation (Washington, D.C., USA) has entered into a partnership with AstraZeneca (Cambridge, UK to develop and commercialize novel diagnostic tools and tests intended to help clinicians... Read more

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Terms of Service
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chem.
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Technology
BioResearch
Industry
Events
Focus
Webinars

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

LabMedica Expo HospiMedica.com Globetech.net

Archive:

BioResearch
COVID-19

2025
MEDLAB 2024
Medica ADLM Medlab 2023
Medica AACC

EUROMEDLAB Medlab 2022
MEDICA AACC ECCMID EUROMEDLAB Medlab 2021
Medica

Copyright © 2000-2025 Globetech Media. All rights reserved.

MOBILE | FULL SITE